524,525 Pancreatic cancer Researchers first compared the expression of GLP-1R in human pancreatic cancer tissues with adjacent non-tumorous pancreatic tissues, finding generally lower or absent expression of GLP-1R in pancreatic cancer tissues
The Wegovy injection is FDA-approved for weight loss in adults and children aged 12 and older with obesity and adults with overweight and at least one weight-related medical condition
For detailed storage timelines by peptide type, see how long reconstituted peptides last in the fridge and at room temperature
However, this comes with significant caveats
Clinical trials indicate an average weight loss between 12% and 17%, with certain participants noting a reduction in body weight as high as 21%
5 Providers should set realistic expectations, encourage lifestyle changes and address barriers such as cost and insurance hurdles